3D Bioprinted Patient-derived Breast Tumor Organoids for CAR T Immunotherapy
3D-Bioprinted Perfusable Vascularized Breast Cancer Model for in vivo Mimicry of Tumor Pathophysiology
A Multipurpose Smartphone-Based Digital Nucleic Acid Amplification Tests (NAATs) Device for Genetic Molecular Diagnosis
A Non-invasive, Quantitative Breast Cancer Diagnosis Method using 3D Mammography
A novel targeted therapy in triple-negative breast cancer
A Phase I clinical trial of SX-682 in combination with Pembrolizumab and Chemotherapy in patients with advanced triple negative breast cancer
A pilot study of continued endocrine therapy with chemotherapy for patients with metastatic HR+/HER2- breast cancer
A small molecule chemoradiotherapy sensitizer for breast cancer
Adaptive Chemotherapeutics as Low Cost Alternatives for Precision Oncology
Adjuvant-like nanofibrous hydrogels for the delivery of peptide vaccines for breast cancer treatment
Aging-related epigenetic regulation of the DDR1 receptor in breast cancer cell reactivation
Alliance of Focused Ultrasound and Myeloid-Targeted Interventions for Metastatic Breast Cancer Immunotherapy
An AI-based Tool for Breast Cancer Diagnosis, Grading, and Tumor Segmentation from Multimodal Data of Scanned Biopsies and Electronic Health Records
Aneuploidy-Associated Metabolic Vulnerabilities in Breast Cancer
Applying precision oncology to improve outcomes for patients with metastatic breast cancer
Associations Between Palpitations and Arrhythmias in Breast Cancer Survivors
Associations between patient-reported financial hardship and clinical trial participation in women with breast cancer receiving care in the deepSouth
Breast Cancer Brain Metastases to the Cerebellum
Breast Cancer Brain Metastasis: New Translational Dimensions
Breast Cancer Diagnostic Response – Understanding Anxiety and Optimism Following Diagnosis, and How These Experiences Impact Distress, Trauma and Surgical Decision Making
Breast Cancer Related Lymphedema Following Immediate Lymphatic Reconstruction and Radiation Therapy
Cancer-Associated Fibroblast Autophagy Promotes Metastasis and Chemotherapy Resistance
CELL CYCLE PLASTICITY IN BREAST CANCER
Characterization of protumorigenic B cells in aggressive breast cancer models
Characterizing the role of the protein phosphatase CPPED1 in triple negative breast cancer
Characterizing translation control driving intratumoral heterogeneity of triple-negative breast cancer
Chemoimmunotherapy for the treatment of metastatic breast cancer
Combination therapy with radiotherapy, immune checkpoint blockade, and curaxin enhances tumor regression in metastatic triple-negative breast cancer
Combining immunogenic chemotherapy with immunotherapy for metastatic triple-negative breast cancer
Comparison of adjunct breast cancer screening with magnetic resonance imaging, molecular breast imaging, and contrast enhanced mammography in patients with history of breast cancer
Computational Discovery and Characterization of Breast Cancer Driver Missense Mutations
Conformable Ultrasound Patch for Breast Tissue Imaging and Early Breast Cancer Screening
"Connection between estrogen, microbiome, and breast
cancer"
Continuous Blood Glucose Monitoring to Assess the Relationship between GlycemicVariability, Chemoresistance, and Toxicities during Neaodjuvant Chemotherapy for Breast Cancer
Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
Deciphering the mechanism and impact of miRNAome alterations in bone metastasis
Deconvoluting the link between PI3K/AKT/mTOR signaling and glycogen for the diagnosis, prognosis, and treatment of breast cancer.
DEFINING METASTASIS-INITIATING CANCER STEM CELLS IN TRIPLE-NEGATIVE BREAST CANCER
DEFINING THE CLINICAL SPACE FOR HDAC6 INHIBITORS IN BREAST CANCER THERAPY
Developing A DNA Foci Assay For Personalized PARP Inhibitor Therapy In Breast Cancer
Developing a screening platform to identify off-target interactions of mischaracterized cancer drugs and discover novel oncoprotein inhibitors
Developing novel triple negative breast cancer therapeutics by engineering selective inhibitors of metalloproteinases
Developing PC-CAR T cells for Breast Cancer
Development of a Multi-level Intervention to Improve Treatment Decision Making in Older Adults with Early-Stage, Hormone Receptor-positive Breast Cancer
Development of next-generation antibodies for breast cancer
Development of novel therapeutic paradigms for treatment-resistant triple-negative breast cancer
Discordant Pathologic Response in the Breast and Axilla to Neoadjuvant Chemotherapy
Discovering a Novel Protein Modification and Its role in Modulating Anti-tumor Immunity in Breast Cancer
Discovering Inhibitors of Polyploid Giant Breast Cancer Cells with Single-Cell Morphological Analysis
Discovery of Novel Elements to Augment NF1 Expression in Breast Cancer Models
Dissecting and modulating myelopoiesis for effective therapy in triple-negative breast cancer
DNA repair deficiency induced by cytosolic BRCA2 mislocalization in breast cancer
Double Jeopardy? Social Determinants of Health and Accelerated Aging in Breast CancerSurvivors
Elucidating the role of anillin in regulation of breast cancer growth and metastasis
Encouraging Uptake of Breast Cancer Screening among Emergency Department Patients
Establishing a robust mouse model of breast cancer cachexia
Evaluating mutagenesis and clonal structure of normal breast tissue and precursor lesions in patients with germline mutations in BRCA1 and BRCA2 genes
Evaluation and Modification of the Decision Aid DecisionKEYs Intervention in High-Risk Breast Cancer Clinic
Evaluation of cerebrospinal fluid tumor and immune microenvironment in patients withmetastatic breast cancer and central nervous system disease
Exploiting FOXA1 synthetic lethality to treat breast cancer
Exploring Statin-Mediated Blockade of B7-H3 Dimerization as a Prevention Strategy for Breast Cancer
Exploring the EMT interplay in Metaplastic Breast Carcinoma
Feasibility and Acceptability of a Peer-Led Support Intervention to Improve Distress among Black Breast Cancer Survivors
Fecal microbiota transplantation to increase the efficacy of immune checkpoint inhibitors and chemotherapy in triple negative breast cancer
Focused Brain Training for Chemotherapy Related Cognitive Impairment in Breast Cancer
Functional Genomics Approaches to Understand Mechanisms of Resistance to Trastuzumab Deruxtecan in HER2-low Breast Cancer
Glycolysis and mitochondrial respiration are druggable metabolic vulnerabilities in triple-negative breast cancer
Gut bacteria composition impacts short-chain fatty acid levels and is associated with differences in mammographic breast density
"Harnessing Mechanical Force as Biophysical
Marker to Prevent Breast Cancer Metastasis"
Harnessing the antimetastatic potential of NK cell-based immunotherapy to eradicate metastatic breast cancer
HER2 PET Imaging to Assess HER2 Heterogeneity and Predict Response to Trastuzumab-Deruxtecan in HER2-low Breast Cancer
Identification of vulnerabilities during transition to the persister state in HER2+ breast cancer
Impact of Neoadjuvant Chemotherapy on Dormant Tumor Cells
Importance of molecular subtyping for the management of triple-negative breast cancer
Improving adherence to oral endocrine therapy for prevention or treatment of breast cancer in patients of low socio-economic status
Improving outcomes with trastuzumab deruxtecan through an innovative phase Icombination trial with neratinib and quantitative HER2 biomarker analysis
Improving the Therapeutic Ratio of Breast Cancer Using Innovative Fasting Strategies
Induction of cell mediated responses against Breast Cancer epitopes using altered carbon ligand peptide vaccines
Influence of Social Determinants of Health and Epigenomics on Psychological Symptom Cluster Severity in Breast Cancer
Inhibition of mutant ER genomic activity by next-generation therapeutic ligands
Integrating gene signatures to guide management of HR+MBC in a diverse cohort (INSIGHT)
Integrating super-resolved Spatial Transcriptomics and histology biobank information to improve ER+ breast cancer recurrence predictions for every single patient
Internet of Things (IoT)-based portable biological sensors for breast cancer detection
Interrogation of the Molecular Origins of Breast Cancer Brain Metastasis
Investigating the RNA modification N6-methyladenosine as a novel target in breast cancer immunotherapy
Leveraging humoral immunity for biomarker and drug discovery in triple negative breast cancer
Mechanistic and functional characterization of DOT1L and Menin-MLL chromatin complexes in estrogen receptor positive breast cancer
Mechanistic basis of anti-CD6 as a novel and safer form of breast cancer immunotherapy
Mechano-transduction in BRCA1/2 Mutation Carriers
Medical Simulation Education Program for Breast Cancer Detection on behalf of Stamford Hospital
Mitochondrial dynamics as a regulator of triple-negative breast cancer
Mitochondrial Network Disrupting (MiND) Nanoparticles for the Treatment of Multidrug Resistant Breast Cancer
Modulating the breast tumor immune microenvironment by targeting CD40
Molecular mechanisms of resistance to novel oral selective estrogen receptor degraders
Mutant selective covalent inhibitor design to target genomic drivers of metastatic breast cancer
Nanoscale physical communication between adipocytes and cancer cells in obesity-associated breast cancer severity
Neutrophil response to the flow-induced sterile inflammation as an indicator of early breast cancer
New Strategies for Targeted Triple-Negative Breast Cancer Therapies
Next generation of clinically translatable indocyanine green based imaging contrast agent platform for breast tumor imaging.
Novel Vaccine Discovery Platform Targeting Structural Variants and RNA Alterations in Triple Negative Breast Cancer (TNBC).
Optimizing systemic treatment for advanced triple negative breast cancer using breast organoids
Pilot trial of the IL-4 receptor antagonist dupilumab plus pembrolizumab, paclitaxel, and carboplatin in locally advanced triple negative breast cancer (TNBC)
Positron Emission Tomography (PET) imaging of copper chelation therapy for triple-negative breast cancer (TNBC) in patient-derived cell and mouse models using the neoadjuvant setting as a translational tool
Precision body composition phenotypes, tumor immunity, and prognosis in triple-negative breast cancer
Predictions of Multi-targeting Drug Response for Breast Cancer Using AI Technique and Single Cell Analysis
"Preventing Metastatic Outgrowth by Targeting Paracrine
Interactions Between Breast Cancer Metastases and the Lung Epithelium"
Radiomics and Genomics – Image Based AI Breast Cancer Risk Assessment in Patients with Germline Mutations
Radionecrosis After Stereotactic Radiosurgery and Trastuzumab Deruxtecan for HER2+ Breast Cancer Brain Metastases
Real-time monitoring of breast cancer therapy response using plasma fragmentomics
Regulation of breast cancer metastasis by desmoplastic ECM via neuronal activation
Role of And-1 in regulation of CFS stability and breast tumorigenesis
Role of chromatin landscape in PARP inhibitor responses in BRCA-mutant breast cancers
Role of signal-induced oxidation of ERK in substrate selection important for cell migration
Role of Type 1 Interferon in Promoting Triple Negative Breast Cancer Aggressiveness in African American Women
Selective targeting of an adaptor function of CDK6 to enhance immunotherapy in TNBC
Sexual Dysfunction in Metastatic Breast Cancer Patients: An Observational Pilot Study
Smartphone-Based Surface Guidance in Radiation Therapy as an Emerging Paradigm in Personalized Breast Cancer Care
Social isolation potentiates breast tumor growth by promoting an immunosuppressive tumor microenvironment.
Statistical inference of cell types and genes in breast tissue causing breast cancers
"Stereotactic Body Radiation Therapy (SBRT) and Estradiol PET (FES-PET) Imaging in Patients with Oligoprogressive
ER+ Metastatic Breast Cancer (MBC)"
Strategies to Facilitate Implementation of Breast Cancer Risk Assessment in Federally Qualified Health Centers
"Stress, HRV, and Inflammation in Breast Cancer Survivors and Their Partners: A Daily Study on Biobehavioral
Health and Cardiovascular Risks."
Study of negative regulation of PTEN by PI3K signaling in HER2+/PIK3CA mutant breast tumors
Study the function of BRCA1 poly-ADP-ribosylation in modulating cell innate immune responses in triple-negative breast cancer
Studying extra chromosomal circular DNA in breast cancers treated with tamoxifen
Studying the cellular and molecular drivers of obesity-accelerated breast cancer
Suppressing myeloid suppression to unlock anti-tumor immunity in breast cancer
"Sustainability of a Pilot Ride Share Intervention: Facilitating a Framework to Enable Large-scale, Inclusive
Patient Access to Preventative Screening"
Targeting BRCA1/2-mutant cancers with folate and vitamin C
Targeting BRD8 to overcome resistance to dual endocrine and anti-HER2 blockade therapy in HR+/HER2+ breast cancer
Targeting Breast Cancers by Secreted Molecules of Normal Fibroblasts on Patient-Derived Organoids
Targeting Cancer Stem Cells in Triple Negative Breast Cancer Enhance Immunotherapy Response
Targeting De Novo Lipogenesis to Enhance Immunotherapy Efficacy in Triple Negative Breast Cancer
Targeting DNA methyltransferases in metastatic triple negative breast cancer Background, Significance & Innovation.
Targeting dysregulated mRNA translation in breast cancer
Targeting exosomal integrin beta 2 for prognostic and therapeutic intervention in breast cancer-associated thromboembolism
Targeting Higher-Order G-Quadruplexes for the Treatment of Triple-Negative Breast Cancer
Targeting macrophages to mitigate radiation induced fibrosis in breast cancer patients
Targeting metabolic dependencies to treat breast cancer brain metastasis
Targeting Novel Breast Cancer Dependencies using De Novo Molecular Glues
Targeting novel mediators of chemotherapy resistance in dormant breast cancer
"TARGETING PERICYTE DERIVED FACTORS DRIVING BREAST CANCER
PROGRESSION"
Targeting Reprogrammed Metabolic Pathways in HER2-positive Breast Cancer with Novel Liver X Receptor Ligands
Targeting RFWD3 in BRCA1/2-Deficient Breast Cancer
Targeting T cell dysfunction during aging to improve immunotherapy in breast cancer
Targeting the immunometabolism of HR+ breast cancer
Telmisartan as a novel, rapidly translated anti-breast cancer agent
The Impact of Breast Cancer Germline Driver Pathogenic Variants on Genome Instability, Carcinogenesis and Drug Sensitivity
The Interplay Between Genomic Rearrangements, Obesity and Response to Neoadjuvant Chemotherapy in Black Women with Triple Negative Breast Cancer
The Role of HSF1 in the Attraction of Immune Cells to Breast Tumors
The use of novel patient engagement technology to improve patient understanding of breast radiology and pathology reports
Therapeutically targeting intercellular integrin-αvβ6 in endocrine therapy-resistant breast cancer
Title
TNBC-on-a-chip for testing cytotoxic microRNA delivery via light-inducible nanoparticles
Topological Machine Learning for Breast Cancer Detection
Understanding and Eliminating Bias in Breast Imaging Artificial Intelligence Algorithms: A Key Step Towards Equity in Outcome for Breast Cancer Patients in the 21st Century
Understanding the epithelial-immune microenvironments in primary tumors and bone metastases of estrogen receptor positive breast cancer
Understanding the role of cancer-associated fibroblast in breast cancer angiogenesis using a vascularization-a-chip model with a matching TME scaffold
Unlocking the Synergistic Potential of CDK4/6 and DDR1 Co-targeting for Advanced Hormone Positive/HER2 Negative Breast Cancer Therapy: A Promising Scientific Approach
Use of a novel artificial intelligence-based mammographic evaluation to assess response to adjuvant endocrine therapy among women with operable breast cancer
Validation and Improvement of an Image-Based AI Model for Early Detection of Breast Cancer
VRK1 as a novel target in triple-negative breast cancers